Matches in Wikidata for { <http://www.wikidata.org/entity/Q81524679> ?p ?o ?g. }
Showing items 1 to 48 of
48
with 100 items per page.
- Q81524679 description "artikull shkencor i botuar më 01 janar 2004" @default.
- Q81524679 description "artículu científicu espublizáu en xineru de 2004" @default.
- Q81524679 description "im Jahr 2004 veröffentlichter wissenschaftlicher Artikel" @default.
- Q81524679 description "scientific article published on 01 January 2004" @default.
- Q81524679 description "wetenschappelijk artikel" @default.
- Q81524679 description "наукова стаття, опублікована в січні 2004" @default.
- Q81524679 name "Biphasic lipid vesicles (Biphasix) enhance the adjuvanticity of CpG oligonucleotides following systemic and mucosal administration" @default.
- Q81524679 name "Biphasic lipid vesicles (Biphasix) enhance the adjuvanticity of CpG oligonucleotides following systemic and mucosal administration" @default.
- Q81524679 name "Biphasic lipid vesicles (Biphasix) enhance the adjuvanticity of CpG oligonucleotides following systemic and mucosal administration" @default.
- Q81524679 type Item @default.
- Q81524679 label "Biphasic lipid vesicles (Biphasix) enhance the adjuvanticity of CpG oligonucleotides following systemic and mucosal administration" @default.
- Q81524679 label "Biphasic lipid vesicles (Biphasix) enhance the adjuvanticity of CpG oligonucleotides following systemic and mucosal administration" @default.
- Q81524679 label "Biphasic lipid vesicles (Biphasix) enhance the adjuvanticity of CpG oligonucleotides following systemic and mucosal administration" @default.
- Q81524679 prefLabel "Biphasic lipid vesicles (Biphasix) enhance the adjuvanticity of CpG oligonucleotides following systemic and mucosal administration" @default.
- Q81524679 prefLabel "Biphasic lipid vesicles (Biphasix) enhance the adjuvanticity of CpG oligonucleotides following systemic and mucosal administration" @default.
- Q81524679 prefLabel "Biphasic lipid vesicles (Biphasix) enhance the adjuvanticity of CpG oligonucleotides following systemic and mucosal administration" @default.
- Q81524679 P1433 Q81524679-A6E57D78-3FF9-4162-8834-F13079668E61 @default.
- Q81524679 P1476 Q81524679-F95780A9-C480-4D63-A78E-4FEDD5EE2BA1 @default.
- Q81524679 P2093 Q81524679-61CE83DB-09A0-487B-9B36-95A34EDE01D6 @default.
- Q81524679 P2093 Q81524679-82032545-EEE2-4F44-8F59-8FB6A5DA1173 @default.
- Q81524679 P2093 Q81524679-8DB53E7D-AFB8-401F-AD03-27CACA15ACAA @default.
- Q81524679 P2093 Q81524679-A3997C91-87DA-412D-BFE6-6EDDF67F1D67 @default.
- Q81524679 P304 Q81524679-ECB6AE55-FBE0-4E6A-AFAF-807330A1C289 @default.
- Q81524679 P31 Q81524679-CF0A6433-0218-40B8-987C-C7B5021BBC39 @default.
- Q81524679 P356 Q81524679-A0AAB084-7E08-405A-B65F-4D4CA6E89F5A @default.
- Q81524679 P433 Q81524679-C2EF8595-D220-41DC-AA97-40CF36DF97EF @default.
- Q81524679 P478 Q81524679-6A652A2B-C960-4F0A-9728-04172132F73F @default.
- Q81524679 P50 Q81524679-4DC04BAD-E5FE-4AB8-8FE2-8279818D11D1 @default.
- Q81524679 P50 Q81524679-628C94DA-51C5-42C7-B2B6-EDD72B3487E5 @default.
- Q81524679 P577 Q81524679-FB0BE17A-4EB7-4092-9DFF-5E4D02B43FA0 @default.
- Q81524679 P698 Q81524679-A6F6918B-132C-4028-9BD7-C6131912078D @default.
- Q81524679 P356 1567201043479993 @default.
- Q81524679 P698 16305366 @default.
- Q81524679 P1433 Q15745388 @default.
- Q81524679 P1476 "Biphasic lipid vesicles (Biphasix) enhance the adjuvanticity of CpG oligonucleotides following systemic and mucosal administration" @default.
- Q81524679 P2093 "Dorothy M Middleton" @default.
- Q81524679 P2093 "Maria E Baca-Estrada" @default.
- Q81524679 P2093 "Marianna Foldvari" @default.
- Q81524679 P2093 "Rolf Hecker" @default.
- Q81524679 P304 "9-15" @default.
- Q81524679 P31 Q13442814 @default.
- Q81524679 P356 "10.2174/1567201043479993" @default.
- Q81524679 P433 "1" @default.
- Q81524679 P478 "1" @default.
- Q81524679 P50 Q114446449 @default.
- Q81524679 P50 Q6681421 @default.
- Q81524679 P577 "2004-01-01T00:00:00Z" @default.
- Q81524679 P698 "16305366" @default.